Covered recipient · General Payments record
TAURUS R ALLEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,116.88
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $500.02 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $193.73 | 10 |
| Novo Nordisk AS | $68.53 | 4 |
| Otsuka America Pharmaceutical, Inc. | $52.42 | 2 |
| DEXCOM, INC. | $49.16 | 3 |
| Amgen Inc. | $35.39 | 2 |
| PFIZER INC. | $30.00 | 1 |
| Merck Sharp & Dohme Corporation | $29.54 | 2 |
| Exact Sciences Corporation | $21.73 | 1 |
| GlaxoSmithKline, LLC. | $19.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.32 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208443 | CMS |
| ABBVIE INC. | $26.70 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208445 | CMS |
| ABBVIE INC. | $2.97 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208447 | CMS |
| ABBVIE INC. | $22.64 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208449 | CMS |
| ABBVIE INC. | $21.43 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208451 | CMS |
| ABBVIE INC. | $27.88 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208453 | CMS |
| ABBVIE INC. | $23.61 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208455 | CMS |
| ABBVIE INC. | $15.36 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208457 | CMS |
| ABBVIE INC. | $21.10 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208459 | CMS |
| ABBVIE INC. | $25.72 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103208461 | CMS |
| Amgen Inc. | $20.88 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117492590 | CMS |
| Amgen Inc. | $14.51 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117492592 | CMS |
| Dexcom, Inc. | $17.02 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339977 | CMS |
| Dexcom, Inc. | $18.48 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339979 | CMS |
| Dexcom, Inc. | $13.66 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339981 | CMS |
| Exact Sciences Corporation | $21.73 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114544039 | CMS |
| GlaxoSmithKline, LLC. | $19.52 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116632887 | CMS |
| Merck Sharp & Dohme LLC | $14.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141984245 | CMS |
| Merck Sharp & Dohme LLC | $14.59 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141617304 | CMS |
| Novo Nordisk Inc | $17.05 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097063089 | CMS |
| Novo Nordisk Inc | $16.38 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097651528 | CMS |
| Novo Nordisk Inc | $16.38 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097106799 | CMS |
| Novo Nordisk Inc | $18.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097526936 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.90 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118851464 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.52 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118851466 | CMS |
| PFIZER INC. | $30.00 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131052274 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.